Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2013

01-02-2013 | Editorial

The Neglected Cousin of the Hepatocyte: How Gallbladder Epithelial Cells Might Contribute to Cholesterol Gallstone Formation

Authors: Arne Dikkers, Uwe J. F. Tietge

Published in: Digestive Diseases and Sciences | Issue 2/2013

Login to get access

Excerpt

The regulation of biliary cholesterol secretion by hepatocytes has received much interest [1], since it has a major impact on two highly relevant disease complexes, namely, the generation of cholesterol gallstones which have an overall prevalence of 10–20 % in developed countries [2] and reverse cholesterol transport [3], an important protective pathway against atherosclerotic cardiovascular disease as well as the main cause for morbidity and mortality in industrialized societies [4]. Less attention has thus far been given to the potential participation of the gallbladder itself in metabolism, which is somewhat surprising, since the gallbladder has the capacity to actively absorb cholesterol from bile and thereby modulate bile cholesterol content [5]. Changes in transporters mediating this metabolic activity of gallbladder epithelial cells could conceivably contribute to cholesterol gallstone formation in disease. However, only a very limited number of studies exist that have functionally explored the relative contributions of known cholesterol transport proteins to cholesterol transport in and out of the gallbladder (Fig. 1).
Literature
1.
go back to reference Dikkers A, Tietge UJ. Biliary cholesterol secretion: more than a simple ABC. World J Gastroenterol. 2010;16:5936–5945.PubMed Dikkers A, Tietge UJ. Biliary cholesterol secretion: more than a simple ABC. World J Gastroenterol. 2010;16:5936–5945.PubMed
2.
go back to reference Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: what it was, what it is, what it will be. World J Gastrointest Pharmacol Ther. 2012;3:7–20.PubMedCrossRef Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: what it was, what it is, what it will be. World J Gastrointest Pharmacol Ther. 2012;3:7–20.PubMedCrossRef
3.
go back to reference Nijstad N, Gautier T, Briand F, Rader DJ, Tietge UJ. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Gastroenterology. 2011;140:1043–1051.PubMedCrossRef Nijstad N, Gautier T, Briand F, Rader DJ, Tietge UJ. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Gastroenterology. 2011;140:1043–1051.PubMedCrossRef
4.
go back to reference Annema W, Tietge UJ. Regulation of reverse cholesterol transport—a comprehensive appraisal of available animal studies. Nutr Metab (Lond). 2012;9:25.CrossRef Annema W, Tietge UJ. Regulation of reverse cholesterol transport—a comprehensive appraisal of available animal studies. Nutr Metab (Lond). 2012;9:25.CrossRef
5.
go back to reference Neiderhiser DH, Harmon CK, Roth HP. Absorption of cholesterol by the gallbladder. J Lipid Res. 1976;17:117–124.PubMed Neiderhiser DH, Harmon CK, Roth HP. Absorption of cholesterol by the gallbladder. J Lipid Res. 1976;17:117–124.PubMed
6.
go back to reference Yoon JH, Choi HS, Jun DW et al. ATP-binding cassette sterol transporters are differentially expressed in normal and diseased human gallbladder. Dig Dis Sci. 2012. (Epub ahead of print). doi:10.1007/s10620-012-2481-0. Yoon JH, Choi HS, Jun DW et al. ATP-binding cassette sterol transporters are differentially expressed in normal and diseased human gallbladder. Dig Dis Sci. 2012. (Epub ahead of print). doi:10.​1007/​s10620-012-2481-0.
7.
go back to reference Tauscher A, Kuver R. ABCG5 and ABCG8 are expressed in gallbladder epithelial cells. Biochem Biophys Res Commun. 2003;307:1021–1028.PubMedCrossRef Tauscher A, Kuver R. ABCG5 and ABCG8 are expressed in gallbladder epithelial cells. Biochem Biophys Res Commun. 2003;307:1021–1028.PubMedCrossRef
8.
go back to reference Miquel JF, Moreno M, Amigo L, et al. Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium. Gut. 2003;52:1017–1024.PubMedCrossRef Miquel JF, Moreno M, Amigo L, et al. Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium. Gut. 2003;52:1017–1024.PubMedCrossRef
9.
go back to reference Erranz B, Miquel JF, Argraves WS, Barth JL, Pimentel F, Marzolo MP. Megalin and cubilin expression in gallbladder epithelium and regulation by bile acids. J Lipid Res. 2004;45:2185–2198.PubMedCrossRef Erranz B, Miquel JF, Argraves WS, Barth JL, Pimentel F, Marzolo MP. Megalin and cubilin expression in gallbladder epithelium and regulation by bile acids. J Lipid Res. 2004;45:2185–2198.PubMedCrossRef
10.
go back to reference Wittenburg H, Lyons MA, Li R, Churchill GA, Carey MC, Paigen B. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology. 2003;125:868–881.PubMedCrossRef Wittenburg H, Lyons MA, Li R, Churchill GA, Carey MC, Paigen B. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology. 2003;125:868–881.PubMedCrossRef
11.
go back to reference von Kampen O, Buch S, Nothnagel M et al. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus. Hepatology. 2012. (Epub ahead of print). doi:10.1002/hep.26009. von Kampen O, Buch S, Nothnagel M et al. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus. Hepatology. 2012. (Epub ahead of print). doi:10.​1002/​hep.​26009.
12.
go back to reference Corradini SG, Elisei W, Giovannelli L, et al. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology. 2000;118:912–920.PubMedCrossRef Corradini SG, Elisei W, Giovannelli L, et al. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology. 2000;118:912–920.PubMedCrossRef
13.
go back to reference Hayashi A, Lee SP. Bidirectional transport of cholesterol between gallbladder epithelial cells and model bile. Am J Physiol. 1996;271:G410–G414.PubMed Hayashi A, Lee SP. Bidirectional transport of cholesterol between gallbladder epithelial cells and model bile. Am J Physiol. 1996;271:G410–G414.PubMed
14.
go back to reference Pramfalk C, Jiang ZY, Parini P. Hepatic Niemann-Pick C1-like 1. Curr Opin Lipidol. 2011;22:225–230.PubMedCrossRef Pramfalk C, Jiang ZY, Parini P. Hepatic Niemann-Pick C1-like 1. Curr Opin Lipidol. 2011;22:225–230.PubMedCrossRef
15.
go back to reference Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res. 2003;44:1728–1736.PubMedCrossRef Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res. 2003;44:1728–1736.PubMedCrossRef
16.
go back to reference Maitra U, Li L. Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin. Arterioscler Thromb Vasc Biol. 2013;33:24–33. Maitra U, Li L. Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin. Arterioscler Thromb Vasc Biol. 2013;33:24–33.
17.
go back to reference Lee J, Shirk A, Oram JF, Lee SP, Kuver R. Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway. Biochem J. 2002;364:475–484.PubMedCrossRef Lee J, Shirk A, Oram JF, Lee SP, Kuver R. Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway. Biochem J. 2002;364:475–484.PubMedCrossRef
18.
go back to reference Della Guardia P, Grossi A, Elisei W, et al. Plasma lipoproteins affect rate of cholesterol absorbed from bile by gallbladder: preliminary data. Ital J Gastroenterol Hepatol. 1999;31:587–592.PubMed Della Guardia P, Grossi A, Elisei W, et al. Plasma lipoproteins affect rate of cholesterol absorbed from bile by gallbladder: preliminary data. Ital J Gastroenterol Hepatol. 1999;31:587–592.PubMed
19.
go back to reference Lee J, Tauscher A, Seo DW, Oram JF, Kuver R. Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E. Am J Physiol Gastrointest Liver Physiol. 2003;285:G630–G641.PubMed Lee J, Tauscher A, Seo DW, Oram JF, Kuver R. Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E. Am J Physiol Gastrointest Liver Physiol. 2003;285:G630–G641.PubMed
20.
go back to reference Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res. 2012;53:1723–1737.PubMedCrossRef Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res. 2012;53:1723–1737.PubMedCrossRef
21.
go back to reference Vassileva G, Golovko A, Markowitz L, et al. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J. 2006;398:423–430.PubMedCrossRef Vassileva G, Golovko A, Markowitz L, et al. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J. 2006;398:423–430.PubMedCrossRef
Metadata
Title
The Neglected Cousin of the Hepatocyte: How Gallbladder Epithelial Cells Might Contribute to Cholesterol Gallstone Formation
Authors
Arne Dikkers
Uwe J. F. Tietge
Publication date
01-02-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2541-5

Other articles of this Issue 2/2013

Digestive Diseases and Sciences 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine